UK Reports First detection of West Nile virus in mosquitoes
On May 21, 2025, A research programme by the UK Health Security Agency (UKHSA) and the Animal and Plant…
Reinvigorated global efforts needed to curb rising malaria threat
On Dec. 11, 2024, the World Health Organization (WHO) reported new data has revealed that an estimated 2.2…
PAHO highlights increase in dengue, Oropouche, and avian influenza cases in the Americas, control measures advised
On Dec. 10, 2024, the Pan American Health Organization (PAHO) reported on three transmissible diseases affecting the Region…
Texas public health officials announced locally acquired case of dengue virus
On Nov. 25, 2024, the Texas Department of State Health Services reported that the first locally acquired case…
Biotechnology | HIV | Infectious Disease | Medicine | Vaccine | WHO
WHO study lists top endemic pathogens for which new vaccines are urgently needed
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
Annual dengue cases double, PAHO urged countries to strengthen response as seasonal transmission began in South America
On Oct. 8, 2024, the Pan American Health Organization (PAHO) announced an epidemiological alert and urged countries in…
San Diego County Reported First Locally Acquired Dengue Case
On Oct. 6, 2024, San Diego County officials announced they were investigating the first ever case of locally…
Biotechnology | Diagnostics | Infectious Disease | Medicine | Therapeutics | Vaccine | WHO
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases
On Oct. 3, 2024,the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP)…
WHO reported a substantial increase in dengue cases globally
On May 30, 2024, the World Health Organization (WHO) reported that as of 30 April 2024, over 7.6…
Chembio received second UNICEF order for $15 Million
On Apr. 8, 2020, Chembio Diagnostics announced a second $1.5 million purchase order from UNICEF for multiplex Zika,…
Chembio Diagnostics received CE Mark for point-of-care multiplex test for Zika, Dengue and Chikungunya
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
Chembio Diagnostics announced approval of Dengue point-of-care test by Brazilis Health Regulatory Agency
On May 7, 2019, Chembio Diagnostics announced the approval of its DPP Dengue System by Agência Nacional de…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
NIH expanded license agreement with Medigen Vaccines Biologics for Dengue vaccine from 17 to 26 countries
On Sept. 18, 2017, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…